Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

BIZARRE: 2 | Mind Blowing Facts

Second patient death reported with gene therapy for muscular dystrophy

Shares of Sarepta Therapeutics have plunged again after the drugmaker reported a second death in connection with its gene therapy for muscular dystrophy

The Independent UK

Pharma Fire Sale: 3 Stocks the RSI Says You Shouldn’t Ignore

These 3 pharma stocks have oversold RSIs and solid analyst support, setting up potential bounce-back trades through this week and next

MarketBeat

Analyst Expectations For Sarepta Therapeutics's Future

14 analysts have expressed a variety of opinions on Sarepta Therapeutics (NASDAQ:SRPT) over the past quarter, offering a diverse set of opinions from bullish to bearish.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Stocks Close Higher on Hopes for U.S. Debt Ceiling Resolution

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.30%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.14%, and the Nasdaq 100 Index ($IU ) (QQQ ) closed up +0.55%. Stock indexes Monday closed moderately higher on hopes that...

Barchart

Stocks Mixed as Hawkish Fed Comments Push Bond Yields Higher

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.03%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.05%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.05%. U.S. stocks this morning gave up an early advance...

Barchart

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the European Commission

1,690 stories

the Wall Street Journal

Bloomberg Intelligence

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.